Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Can B (CANB) Competitors

Can B logo

CANB vs. MEDS, BIMI, HCWB, ATNF, FRTX, NRBO, IMCC, BGLC, QNRX, and KTTA

Should you be buying Can B stock or one of its competitors? The main competitors of Can B include TRxADE HEALTH (MEDS), BIMI (BIMI), HCW Biologics (HCWB), 180 Life Sciences (ATNF), Fresh Tracks Therapeutics (FRTX), NeuroBo Pharmaceuticals (NRBO), IM Cannabis (IMCC), BioNexus Gene Lab (BGLC), Quoin Pharmaceuticals (QNRX), and Pasithea Therapeutics (KTTA). These companies are all part of the "medical" sector.

Can B vs. Its Competitors

Can B (NASDAQ:CANB) and TRxADE HEALTH (NASDAQ:MEDS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

In the previous week, TRxADE HEALTH had 1 more articles in the media than Can B. MarketBeat recorded 1 mentions for TRxADE HEALTH and 0 mentions for Can B. TRxADE HEALTH's average media sentiment score of 0.00 beat Can B's score of -0.14 indicating that TRxADE HEALTH is being referred to more favorably in the news media.

Company Overall Sentiment
Can B Neutral
TRxADE HEALTH Neutral

Can B has higher earnings, but lower revenue than TRxADE HEALTH.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Can B$2.16M0.58-$9.74MN/AN/A
TRxADE HEALTH$7.45M0.27-$17.84MN/AN/A

Can B has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500. Comparatively, TRxADE HEALTH has a beta of 2.32, suggesting that its stock price is 132% more volatile than the S&P 500.

TRxADE HEALTH has a net margin of -149.81% compared to Can B's net margin of -1,238.33%. Can B's return on equity of 0.00% beat TRxADE HEALTH's return on equity.

Company Net Margins Return on Equity Return on Assets
Can B-1,238.33% N/A -218.65%
TRxADE HEALTH -149.81%-196.79%-112.21%

6.1% of Can B shares are held by institutional investors. Comparatively, 5.7% of TRxADE HEALTH shares are held by institutional investors. 11.4% of Can B shares are held by company insiders. Comparatively, 48.4% of TRxADE HEALTH shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

TRxADE HEALTH beats Can B on 7 of the 11 factors compared between the two stocks.

Get Can B News Delivered to You Automatically

Sign up to receive the latest news and ratings for CANB and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CANB vs. The Competition

MetricCan BDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ Exchange
Market Cap$1.26M$2.79M$5.52B$9.02B
Dividend YieldN/AN/A5.24%4.05%
P/E RatioN/AN/A27.2520.08
Price / Sales0.580.27371.3293.25
Price / CashN/AN/A26.2128.59
Price / Book-0.053.227.945.55
Net Income-$9.74M-$17.84M$3.17B$248.49M

Can B Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CANB
Can B
N/A$0.02
+2.7%
N/A+46.0%$1.26M$2.16M0.0016Gap Up
MEDS
TRxADE HEALTH
N/A$1.04
+11.2%
N/A-91.4%$1.46M$7.45M0.0050
BIMI
BIMI
N/A$0.00
flat
N/AN/A$1K$12.63M0.00520
HCWB
HCW Biologics
3.3269 of 5 stars
$3.75
-5.3%
$35.00
+833.3%
-83.2%$5.71M$2.57M-0.1640
ATNF
180 Life Sciences
0.5821 of 5 stars
$0.89
-4.1%
N/A-48.7%$5.63MN/A0.007
FRTX
Fresh Tracks Therapeutics
N/A$0.94
-0.5%
N/A-0.5%$5.59M$10.06M-0.6620
NRBO
NeuroBo Pharmaceuticals
N/A$0.64
+2.1%
N/A-85.7%$5.54MN/A0.0010Gap Up
IMCC
IM Cannabis
0.334 of 5 stars
$2.70
+8.9%
N/A+31.3%$5.54M$39.44M-4.22340
BGLC
BioNexus Gene Lab
0.4191 of 5 stars
$11.14
+262.9%
N/A+27.8%$5.52M$9.51M0.0030High Trading Volume
QNRX
Quoin Pharmaceuticals
0.5201 of 5 stars
$9.23
flat
N/A-56.2%$5.43MN/A-0.194
KTTA
Pasithea Therapeutics
0.99 of 5 stars
$0.73
+1.8%
N/A-85.9%$5.37MN/A-0.073Positive News

Related Companies and Tools


This page (NASDAQ:CANB) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners